Is Bluebird Bio, Inc. (blue) Worth A Look?

Recent good news at Bluebird Bio, Inc. (Blue) - worth a look?



Dec-07-17

Bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy Business Wire +5.33%
Here's Why bluebird bio's Shares Soared 24% in November Motley Fool

Dec-05-17

Bluebird Bio (BLUE) Bullish Camp Just Got Stronger SmarterAnalyst

 

Absolutely. I sold 10 of my last 20 shares yesterday well above $200, so it's a little hot right now. But it's a very good company with excellent drugs in their pipelines.

I will likely add to my position again when it cools off. I've been in and out of this one over the last couple of years, and when I last took a new position here in late June, it was trading just over $100. So it's had a big runup in a short time for a multi-billion dollar company.

 

Looks like the buyers have been chipping away and then the shares finally spiked prompting a bout of profit taking - potentially an interesting buy on weakness as you say

 

https://www.zacks.com/stock/news/28...ata-for-cart-therapy?cid=CS-MKTWTCH-HL-285678

 

Some analysts have set price targets above $300 on it in light of the latest drug info.

 

I'll probably be buying a little more of it soon.

 

These biotechs are like that - when they get a drug approval or other good news, most of them spike up dramatically, then tend to fall back down a fair amount.

They're very volatile - particularly the smaller ones that may be as little as 7 figures in market cap and that often trade at very low prices.

I tend to own many of these biotechs and in small amounts - when the news is bad, they're known to fall as much as 70-80% overnight in some cases. Diversification and careful handling of these is essential if you're going to play with them.